Ferran Fece de la Cruz, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Design | 1 | 2014 | 1046 | 0.330 |
Why?
|
Cholangiocarcinoma | 2 | 2024 | 561 | 0.260 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2830 | 0.230 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1767 | 0.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8647 | 0.200 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2024 | 212 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 5 | 2024 | 5703 | 0.180 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2019 | 69 | 0.170 |
Why?
|
Bile Duct Neoplasms | 1 | 2024 | 614 | 0.150 |
Why?
|
Neoplasms | 2 | 2018 | 22371 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2019 | 564 | 0.120 |
Why?
|
Pyridines | 2 | 2024 | 2894 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2024 | 2885 | 0.120 |
Why?
|
Exons | 1 | 2019 | 2394 | 0.110 |
Why?
|
Haploidy | 1 | 2013 | 127 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2024 | 13676 | 0.110 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3833 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2004 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 998 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1494 | 0.100 |
Why?
|
Mutagenesis, Insertional | 1 | 2013 | 661 | 0.090 |
Why?
|
Gene Library | 1 | 2013 | 1064 | 0.090 |
Why?
|
Cell Death | 1 | 2014 | 1679 | 0.080 |
Why?
|
Mutation | 7 | 2024 | 30238 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2024 | 7876 | 0.070 |
Why?
|
DNA Methylation | 2 | 2018 | 4428 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1752 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2024 | 17140 | 0.060 |
Why?
|
Pyrimidines | 3 | 2024 | 3048 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7608 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5341 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3239 | 0.050 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6974 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2024 | 304 | 0.050 |
Why?
|
Piperazines | 2 | 2024 | 2554 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2016 | 10474 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5432 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 525 | 0.040 |
Why?
|
Signal Transduction | 3 | 2024 | 23645 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 905 | 0.040 |
Why?
|
Histone Code | 1 | 2018 | 160 | 0.040 |
Why?
|
Diphenylamine | 1 | 2016 | 49 | 0.030 |
Why?
|
Azacitidine | 1 | 2018 | 336 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2024 | 21206 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 531 | 0.030 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13586 | 0.030 |
Why?
|
Feedback | 1 | 2019 | 799 | 0.030 |
Why?
|
Introns | 1 | 2018 | 966 | 0.030 |
Why?
|
Humans | 11 | 2024 | 768166 | 0.030 |
Why?
|
Urea | 1 | 2016 | 448 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2018 | 725 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2016 | 386 | 0.030 |
Why?
|
Oncogenes | 1 | 2019 | 1234 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3055 | 0.030 |
Why?
|
Calcium-Binding Proteins | 1 | 2018 | 1083 | 0.030 |
Why?
|
Thiophenes | 1 | 2016 | 570 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6124 | 0.020 |
Why?
|
ras Proteins | 1 | 2016 | 1058 | 0.020 |
Why?
|
Pyridones | 1 | 2016 | 819 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1613 | 0.020 |
Why?
|
Benzamides | 1 | 2016 | 1379 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6231 | 0.020 |
Why?
|
Mice, Nude | 1 | 2016 | 3623 | 0.020 |
Why?
|
Animals | 3 | 2019 | 169246 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4146 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2629 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3611 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2832 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5797 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2059 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2018 | 12800 | 0.010 |
Why?
|
Aged | 3 | 2019 | 171504 | 0.010 |
Why?
|
Female | 4 | 2024 | 397192 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17622 | 0.010 |
Why?
|
Middle Aged | 3 | 2019 | 223492 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4446 | 0.010 |
Why?
|
Male | 3 | 2019 | 364719 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20760 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65371 | 0.010 |
Why?
|
Mice | 1 | 2019 | 82029 | 0.010 |
Why?
|
Adult | 1 | 2019 | 223646 | 0.000 |
Why?
|